Critical Pharmaceuticals
HomeCompany ProfileNewsTechnologyManagement TeamPipelineEventsContact Us

Latest News

6th September 2011
  Interim Results of CP024 Nasal hGH Phase 1 Program Show Comparable Bioactivity to Injection
5th April 2011
  PolyTherics and Critical Pharmaceuticals enter drug development collaboration with TSB funding
8th March 2011
  CriticalSorb Delivery Technology Shows Excellent Local Tolerability in Long Term Preclinical Studies
Technology
 

Technology

Critical Pharmaceuticals has developed two unique drug delivery technologies:

CriticalSorb for the non-invasive nasal delivery delivery of high-value biologic products and challenging small molecule drugs.

CriticalMix for the manufacture of highly active sustained release depot products for bimonthly, monthly or even less frequent injection.

 

 
 

 

Events

Event Date / Location Attendee

Drug Delivery Partnerships

25-27 Jan, 2012 Las Vegas, NV

Dr Andy Lewis, Director Operations

www.iirusa.com/ddp

UK - India Innovation and Leadership Meeting

5-6 March, 2012 Bangalore, India

Dr Gareth King, CEO

www.biopharm2020.org

BIO-Europe 19-21 March, 2012 Amsterdam, The Netherlands

Dr Gareth King, CEO

www.ebdgroup.com

SMi Controlled Release

28-29 March, 2012 London, UK

Dr Andy Lewis, Director Operations

www.smi-online.co.uk

BioTrinity

25-26 April, 2012 Newbury, UK

Dr Gareth King, CEO

www.biotrinity.com

 

EPIC Biotech

31 May, 2012 London, UK

Dr Gareth King, CEO

www.epicbiotech.com

BIO International Convention

18-21 June, 2012 Boston, MA

Dr Gareth King, CEO

convention.bio.org

ENDO 2012

23-26 June, 2012 Houston, TX

Dr Andy Lewis, Director Operations

www.endo-society.org